LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 9,737,729 Value ($000) $5,239 Avg Close — Range —
Q4 2024
Shares 9,766,083 Value ($000) $6,250 Avg Close — Range —
Q3 2024
Shares 10,071,482 Value ($000) $13,899 Avg Close — Range —
Q2 2024
Shares 13,398,298 Value ($000) $19,428 Avg Close — Range —
Q1 2024
Shares 13,388,425 Value ($000) $29,856 Avg Close — Range —
Q4 2023
Shares 13,604,027 Value ($000) $26,392 Avg Close — Range —
Q3 2023
Shares 16,909,720 Value ($000) $24,857 Avg Close — Range —
Q2 2023
Shares 16,877,253 Value ($000) $53,670 Avg Close — Range —
Q1 2023
Shares 12,759,123 Value ($000) $30,112 Avg Close — Range —
Q4 2022
Shares 12,591,230 Value ($000) $43,692 Avg Close — Range —
Q3 2022
Shares 12,406,613 Value ($000) $90,940 Avg Close — Range —
Q2 2022
Shares 10,629,996 Value ($000) $69,307 Avg Close — Range —
Q1 2022
Shares 8,778,702 Value ($000) $44,332 Avg Close — Range —
Q4 2021
Shares 2,143,088 Value ($000) $16,588 Avg Close — Range —
Q3 2021
Shares 2,212,819 Value ($000) $32,749 Avg Close — Range —
Q2 2021
Shares 1,749,378 Value ($000) $28,410 Avg Close — Range —